Viewing Study NCT07170592


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2026-01-07 @ 2:52 PM
Study NCT ID: NCT07170592
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-29
First Post: 2025-07-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients
Sponsor: Bionoxx Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module